Virchows Arch (2017) 471:137–140 DOI 10.1007/s00428-017-2198-8 EDITORIAL 1 2 Fred T. Bosman & George J. Netto Published online: 17 July 2017 Springer-Verlag GmbH Deutschland 2017 Pathology as a clinical diagnostic discipline is not quite being papers discussing general issues and closes with papers re-invented, but there is no doubt that if Rudolph Virchow reviewing the current status of the role of pathology in select- could have made a Bback to the future^ maneuver, he would ed areas of molecular medicine. have been highly impressed. His paradigm of Bcellular^ pa- The opening paper by Kaul (DOI 10.1007/s00428-017- thology being replaced by that of Bmolecular^ pathology! Is 2141-z) concludes that molecular (Bgenomic^)analysesare this change in focus really a paradigm shift? Not necessarily. becoming standard in the assessment of the pathology of One way to think about this is that three decades ago diagnos- cancer. Methods and equipment remain in rapid tic histopathology had as endpoint what one could do with development, which continuously expands areas of classical morphology: reading patterns of gene expression application. Standardization and quality assurance are the without knowing which genes were involved. What makes responsibilities of pathologists and indeed consensus today’s pathology so exciting is that gradually
Virchows Archiv – Springer Journals
Published: Jul 17, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera